Sen-Jam Pharmaceutical Announces Upcoming Completion of SJP-002C Clinical Trial, Offering Hope for a Safe, Potent, and Globally Affordable Treatment for Upper Respiratory Infections and COVID-19

Press/Media

Period22 May 2024

Media coverage

23

Media coverage